- Home
- ALKS vs PK Comparison
ALKS vs PK Comparison
Compare ALKS & PK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALKS
- PK
- Stock Information
- Founded
- ALKS 1987
- PK 1946
- Country
- ALKS Ireland
- PK United States
- Employees
- ALKS N/A
- PK N/A
- Industry
- ALKS Biotechnology: Pharmaceutical Preparations
- PK Real Estate Investment Trusts
- Sector
- ALKS Health Care
- PK Real Estate
- Exchange
- ALKS Nasdaq
- PK Nasdaq
- Market Cap
- ALKS 4.7B
- PK 2.9B
- IPO Year
- ALKS 1991
- PK N/A
- Fundamental
- Price
- ALKS $26.86
- PK $14.13
- Analyst Decision
- ALKS Buy
- PK Buy
- Analyst Count
- ALKS 11
- PK 13
- Target Price
- ALKS $36.70
- PK $17.77
- AVG Volume (30 Days)
- ALKS 1.3M
- PK 2.0M
- Earning Date
- ALKS 10-23-2024
- PK 10-30-2024
- Dividend Yield
- ALKS N/A
- PK 7.08%
- EPS Growth
- ALKS 179.95
- PK N/A
- EPS
- ALKS 1.70
- PK 1.44
- Revenue
- ALKS $1,507,916,000.00
- PK $2,666,000,000.00
- Revenue This Year
- ALKS N/A
- PK N/A
- Revenue Next Year
- ALKS N/A
- PK $2.80
- P/E Ratio
- ALKS $11.82
- PK $9.79
- Revenue Growth
- ALKS 3.14
- PK N/A
- 52 Week Low
- ALKS $22.01
- PK $11.05
- 52 Week High
- ALKS $32.88
- PK $18.05
- Technical
- Relative Strength Index (RSI)
- ALKS 45.08
- PK 41.80
- Support Level
- ALKS $27.85
- PK $14.77
- Resistance Level
- ALKS $28.66
- PK $15.35
- Average True Range (ATR)
- ALKS 0.61
- PK 0.38
- MACD
- ALKS -0.20
- PK -0.05
- Stochastic Oscillator
- ALKS 6.63
- PK 3.54
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
About PK Park Hotels & Resorts Inc.
Park Hotels & Resorts owns upper-upscale and luxury hotels with 23,428 rooms across 39 hotels in the United States. Park also has interests through joint ventures in another 2,665 rooms in four U.S. hotels. Park was spun out of narrow-moat Hilton Worldwide Holdings at the start of 2017, so most of the company's hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality U.S. hotels to focus on high-quality assets in domestic gateway markets.